Insider sales are trivial relative to market cap and consistent with routine vesting/liquidity. No bearish signal. Monitor for any material corporate events (earnings, pipeline updates) that could change the outlook, but this cluster alone does not warrant action.
PGEN drugs
PGEN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 4 $6.53entry
- T+1 · 3mo ago +5.51%α +5.71% · $6.89
- T+5 · 3mo ago +5.05%α +5.15% · $6.86
- T+20 · 3mo ago +5.05%α +6.29% · $6.86
- T+60 · 20d ago −5.82%α −6.20% · $6.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Precigen insiders (CFO and COO) sold a combined $826K in open-market sales over a 4-day window. The CFO sold $606K at $6.06, and the COO sold $220K at $6.50 after exercising derivatives. At a $2.2B market cap, these sales represent ~0.04% of market cap, well below the 0.1% materiality threshold, and are likely routine liquidity/vesting-related sales rather than a bearish signal. The cluster is not amplified by the proportionality band, and the COO's sale directly follows a derivative exercise (same-day same-share-count), confirming a tax/vesting pattern. No bearish read-through warranted.
Key Financial Metrics
Key Facts
- CFO Thomasian sold 100,000 shares at $6.06 for $606K on 2026-07-31
- COO Shah sold 33,772 shares at $6.50 for $220K on 2026-08-03, following a same-day derivative exercise of 33,772 shares at $0
- COO also exercised 33,772 shares at $2.33 for $78,689 on 2026-08-03 (non-cash exercise)
- Total open-market sales: $826K, representing ~0.04% of $2.2B market cap
- No open-market purchases in the cluster
Financial Impact
Total insider sales of $826K, negligible relative to $2.2B market cap (0.04%)
Risk Factors
- Insider sales could accelerate if stock price rises further
- No purchases to signal conviction from management
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PGEN-1785795196323 |
Track record
13 reports on PGEN
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +52.17% at T+60 after the May 13, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $4.22 to $4.66 Now $4.30 +1.90% ▲ +10.43% +7.14% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 3/10 Entry $6.93 to $6.99 Now $4.30 −37.95% ▲ +0.79% +0.94% vs SPY
- Aug 26, 202611w ago 144 Neutral 3/10 Entry $7.19 to $7.14 Now $4.30 −40.19% ▼ −0.70% −0.96% vs SPY
- Aug 25, 202611w ago Insider Cluster Bearish 4/10 Entry $7.42 to $7.01 Now $4.30 +42.05% ▲ +5.53% +5.41% vs SPY
- Aug 25, 202611w ago Insider Cluster Neutral 2/10 Entry $7.42 to $7.01 Now $4.30 −42.05% ▼ −5.53% −5.41% vs SPY
- Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $7.00 to $6.55 Now $4.30 −38.57% ▼ −6.43% −6.38% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Viewing Entry $6.53 to $6.86 Now $4.30 −34.15% ▲ +5.05% +5.15% vs SPY
- Jul 1, 202619w ago Insider Cluster Bearish 5/10 Entry $5.64 to $5.53 Now $4.30 +23.76% ▲ +1.95% +2.88% vs SPY
- Jun 24, 202620w ago 8-K Neutral 3/10 Entry $5.52 to $5.25 Now $4.30 −22.10% ▼ −4.89% −6.45% vs SPY
- Jun 1, 202624w ago Insider Cluster Neutral 3/10 Entry $3.86 to $3.71 Now $4.30 +11.40% ▼ −3.89% −0.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers